Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD STAT: Simvastatin in Parkinson's Disease
NCT02787590Phase 2Completed
- Sponsor
- University Hospitals Plymouth
- Start
- Mar 2016
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Simvastatin with Matched Placebo (2 arms). Primary endpoint: Change in MDS-UPDRS part III (OFF) score at 24 months. Started Mar 2016; status: completed.
02
Drugs
simvastatin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02787590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787590.